Intravascular Optical Coherence Tomography (IVOCT)
February 25, 2022
Dyad Medical Secures FDA Clearance For Cardiac Image Analysis Platform
February 25, 2022 – Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis…
Read More
February 25, 2022
Breakthrough Study Uses Genetic Testing to Evaluate Risk of Heart Disease
February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic…
Read More
The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
February 24, 2022
FDA Approves Empagliflozin for Reducing Risk of Heart Failure
February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of…
Read More
The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil lawsuit today to stop UnitedHealth Group Incorporated (United) from acquiring Change Healthcare Inc. (Change).
February 24, 2022
Justice Department Sues to Block UnitedHealth Group’s Acquisition of Change Healthcare
February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil…
Read More
We are at the precipice of a huge development in patient care, with the first smart hospital already announced last year in Southeast Asia. To keep pace, governments in the US and Europe need to increase investment in 5G networks, as these will be essential to meet the high network demands.
February 24, 2022
Significant Expansion of 5G Networks Could be the Catalyst Towards Smart Hospitals
February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you…
Read More
Scientists have already discovered that the gut microbiome is altered in people with chronic heart disease. They subsequently identified compounds that are produced by the diseased microbiome, for instance a bacterial compound called trimethylamine (TMA) that after modification in the liver of the human host causes arteriosclerosis.
February 21, 2022
Scientists Characterize the Imbalanced Gut Bacteria of Patients with Myocardial Infarction, Angina and Heart Failure
February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may…
Read More
Researchers at Gladstone; Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.
February 21, 2022
Getting to the Heart of Complex Disease
February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-…
Read More
Angioscopic findings in the FPA and infrapopliteal lesions
February 21, 2022
Study Finds Ulcerated Plaque in the Femoropopliteal Artery as Source of Arterial Embolism in the Popliteal Arteries
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School…
Read More
An ultrasound is taken of a patient's heart.
February 21, 2022
A Non-invasive Way to Predict Heart Attack and Stroke
February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and…
Read More
Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening heart failure through its randomized controlled trial, Ultrafiltration Versus IV Diuretics in Worsening Heart Failure, the REVERSE-HF Study.
February 21, 2022
Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload
February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of…
Read More
Pipeline for creating synthetic images and validation process.
February 21, 2022
New Tool for 3-D Measurement of the Aorta May Identify Fatal Heart Conditions Earlier
February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s…
Read More
Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 
February 18, 2022
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has…
Read More
Daxor’s Blood Volume (BVA-100) Diagnostic
February 18, 2022
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure
February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data…
Read More
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
February 18, 2022
Front Line Medical Technologies Expands Availability of its COBRA-OS
February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of…
Read More
Already used in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for adult patients, Rapiscan is now approved for use in stress cardiac magnetic resonance imaging (CMR)
February 18, 2022
GE Healthcare’s Stress Agent Rapiscan Approved for use in Stress Cardiac Magnetic Resonance Imaging
February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA)…
Read More
Clinical Case of the Month
February 17, 2022
Call for Entries!
We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case…
Read More
Myocarditis (inflammation of the heart muscle) after vaccination is rare, but some cases have been reported after receipt of the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccine.
February 17, 2022
COVID Vax–related Myocarditis May be Milder Than That of Other Causes
February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as…
Read More
Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is leveraging its capabilities in the cardiology space with its new Cloud for Cardiology.
February 17, 2022
Mytonomy Announces Cardiology Content and Platform
February 17, 2022 – Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is…
Read More
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
By Melinda Taschetta-Millane
February 16, 2022
Pig Heart Transplant Patient Continues to Thrive
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC)…
Read More
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System,
February 16, 2022
Elixir Medical Completes Enrollment in Bioadaptor Randomized Controlled Trial of DynamX Coronary Bioadaptor System
February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now